MENS
Jyong Biotech Ltd. Ordinary Shares
NASDAQ · Healthcare · Biotechnology · TW
$2.39
+5.29%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
18.8%
Return on equity
-22.5%
Return on assets
41.0%
Return on invested capital
0.00x
Asset turnover
-$3.0M
Cash from operations
$0.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025